Publication | Open Access
Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma – Data from the prospective, multicenter phase III HD16 trial
33
Citations
24
References
2022
Year
ClinicalTrials.gov NCT00736320 .
| Year | Citations | |
|---|---|---|
Page 1
Page 1